Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07459790 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis With Hunner's Lesions

StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
To evaluate the efficacy and safety of Neovasculgen in interstitial cystitis with Hunner's lesions to reduce cicatricial changes in the bladder caused by electrocoagulation and to prevent secondary bladder shrinkage with a decrease in its volume.
Trial Details
NCT Number NCT07459790
Lead Sponsor JSC NextGen
Conditions
(from sponsor)		 IC, Hunner Type Interstitial Cystitis, Bladder Pain Syndrome
Related terms Cystitis, Interstitial
Enrollment 180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov